Connect with us

Health

Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence – News-Medical.Net

Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone…

Published

on

Article feature image
ADVERTISEMENT

Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The study, published in Blood Advances,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending